Back to top

BioCryst appoints Charlie Gayer to succeed Jon Stonehouse as CEO

BioCryst appoints Charlie Gayer to succeed Jon Stonehouse as CEO

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

BioCryst Pharmaceuticals, Inc. (BCRX)